Additive BioFabrication produces complex structures from biological materials such as cells and biomaterials; this emerging technology has the potential to support a design-led manufacturing approach for the production of in vitro models used for drug discovery and development, cell based clinical therapies and biotechnology applications.

The University of Nottingham is active in this research area, with state-of-the-art facilities and 3D printing equipment, including mammalian and prokaryotic cell culture and 3D imaging, enabling BioFabrication at nano, micro and macro scales. Outputs from the research allows collaborators and stakeholders to replicate and build bioinspired 3D structures that can be used to direct cell phenotype and behaviour.

During the webinar you will get an overview about Nottingham’s BioFabrication Centre and learn about various case studies. There will also be break out rooms to discuss the barriers to adoption of additive biofabrication technologies within industry.

Agenda

10.00 Welcome and housekeeping (Dana Heldt, KTN)

10.05 Introduction to the KTN (Dana Heldt, KTN)

10.15 Introduction to the IRC Additive BioFabrication (Felicity Rose, UoN)

10.25 Aims for the day (Felicity Rose, UoN)

10:30 Additive Manufacturing case studies

  • Pharmaceuticals (Ricky Wildman)
  • Regenerative medicine (Felicity Rose)
  • Industry perspective (TBC)

11:15 Panel discussion and QA

11.25 Breakout sessions: What are the barriers to adoption of additive biofabrication technologies within industry?

11:55 Wrap up

12:00 End of meeting

Register